Regulation

Healthcare Bolsters Security Against AI Cyber Threats
Technology Healthcare Bolsters Security Against AI Cyber Threats

The rapid convergence of advanced artificial intelligence and interconnected medical infrastructure has fundamentally altered the protective requirements for sensitive patient health information and clinical operational stability. This digital transformation of patient care delivery has

Can We Trust Clinical AI Without Independent Validation?
Public Policy Can We Trust Clinical AI Without Independent Validation?

A high-stakes patient screening algorithm fails to identify a critical cardiac anomaly despite having received formal regulatory clearance months prior, leaving clinicians to grapple with the reality that marketing claims often outpace clinical reality. This scenario has become increasingly common

How Will Germany Regulate Digital Health in 2026?
Data and Information How Will Germany Regulate Digital Health in 2026?

The transformation of the German healthcare system from a legacy paper-bound hierarchy into a streamlined digital powerhouse has reached a defining milestone, fundamentally altering how eighty-three million citizens interact with medical professionals and insurance providers on a daily basis. By

How Will the First Golimumab Biosimilars Impact Treatment?
Care How Will the First Golimumab Biosimilars Impact Treatment?

The healthcare landscape shifted significantly in May 2026 when the FDA granted approval to the first biosimilar versions of golimumab, marking a new chapter for millions of patients. This regulatory milestone introduced Immgolis and Immgolis Intri as alternatives to the established reference

Medicare Advantage Market Reset Prioritizes Value Over Scale
Care Medicare Advantage Market Reset Prioritizes Value Over Scale

The long-standing architectural foundations of the American private insurance landscape are currently shaking as the Medicare Advantage program undergoes a fundamental structural realignment that favors clinical precision over the historical dominance of massive enrollment figures. While the

PBM Lobby Sues Illinois to Block New Drug Oversight Law
Care PBM Lobby Sues Illinois to Block New Drug Oversight Law

The legislative battle over prescription drug pricing has reached a fever pitch in the Midwest as the primary trade group for pharmacy benefit managers has officially filed a federal lawsuit against the state of Illinois. This legal challenge targets the newly enacted Healthcare Protection Act, a

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later